BL PharmTech Corp
KOSDAQ:065170
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
B
|
BL PharmTech Corp
KOSDAQ:065170
|
144.9B KRW |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
198.4B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
118.4B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
36.7B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
38.9B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.5B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3.1T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
909B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
BL PharmTech Corp
Glance View
BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for BL PharmTech Corp is 57.3%, which is above its 3-year median of 45%.
Over the last 3 years, BL PharmTech Corp’s Gross Margin has increased from 22.9% to 57.3%. During this period, it reached a low of 18.4% on Sep 30, 2023 and a high of 67.2% on Dec 31, 2024.
